Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-31

Clinical Trial Update: Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating fecal microbiota transplantation for improving tolerance to enteral nutrition in ICU patients with gastrointestinal dysfunct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance | Phase 2, Phase 3 | Status: COMPLETED